BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18562398)

  • 1. Use of disease risk scores in pharmacoepidemiologic studies.
    Arbogast PG; Ray WA
    Stat Methods Med Res; 2009 Feb; 18(1):67-80. PubMed ID: 18562398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.
    Arbogast PG; Ray WA
    Am J Epidemiol; 2011 Sep; 174(5):613-20. PubMed ID: 21749976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.
    Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2006 May; 15(5):291-303. PubMed ID: 16447304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient sampling approaches to address confounding in database studies.
    Hanley JA; Dendukuri N
    Stat Methods Med Res; 2009 Feb; 18(1):81-105. PubMed ID: 18815164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of propensity score technique to account for exposure-related covariates: an example and lesson.
    Seeger JD; Kurth T; Walker AM
    Med Care; 2007 Oct; 45(10 Supl 2):S143-8. PubMed ID: 17909373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjustment for multiple cardiovascular risk factors using a summary risk score.
    Arbogast PG; Kaltenbach L; Ding H; Ray WA
    Epidemiology; 2008 Jan; 19(1):30-7. PubMed ID: 18091000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity scores: an introduction and experimental test.
    Luellen JK; Shadish WR; Clark MH
    Eval Rev; 2005 Dec; 29(6):530-58. PubMed ID: 16244051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations.
    Bohn J; Eddings W; Schneeweiss S
    Am J Epidemiol; 2017 Mar; 185(6):501-510. PubMed ID: 28399565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of different propensity-score methods for estimating relative risks.
    Austin PC
    J Clin Epidemiol; 2008 Jun; 61(6):537-45. PubMed ID: 18471657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of critical care.
    LaRovere JM; Jeffries HE; Sachdeva RC; Rice TB; Wetzel RC; Cooper DS; Bird GL; Ghanayem NS; Checchia PA; Chang AC; Wessel DL
    Cardiol Young; 2008 Dec; 18 Suppl 2():130-6. PubMed ID: 19063783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity scores: from naive enthusiasm to intuitive understanding.
    Williamson E; Morley R; Lucas A; Carpenter J
    Stat Methods Med Res; 2012 Jun; 21(3):273-93. PubMed ID: 21262780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry.
    Quartey G; Wang J; Kim J
    Pharm Stat; 2011; 10(6):548-53. PubMed ID: 22127819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case-crossover study design in pharmacoepidemiology.
    Delaney JA; Suissa S
    Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounting for time-dependent covariates whose levels are influenced by exposure status.
    Weiss NS; Dublin S
    Epidemiology; 1998 Jul; 9(4):436-40. PubMed ID: 9647909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of disease-risk score in pharmacoepidemiologic studies].
    Zhao HY; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):261-266. PubMed ID: 28231678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An empirically based tool for analyzing mortality associated with congenital heart surgery.
    O'Brien SM; Clarke DR; Jacobs JP; Jacobs ML; Lacour-Gayet FG; Pizarro C; Welke KF; Maruszewski B; Tobota Z; Miller WJ; Hamilton L; Peterson ED; Mavroudis C; Edwards FH
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1139-53. PubMed ID: 19837218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach.
    Qu Y; Lipkovich I
    Stat Med; 2009 Apr; 28(9):1402-14. PubMed ID: 19222021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.